Yaerim Kim

Prof. Yaerim Kim

Keimyung University Dongsan Hospital, Keimyung University School of Medicine
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
PDF file
SPSehoon Park
Sehoon Park
SLSoojin Lee
Soojin Lee
YKYaerim Kim
Yaerim Kim
YLYeonhee Lee
Yeonhee Lee
MKMin Woo Kang
Min Woo Kang
DKDong Ki Kim
Dong Ki Kim
Significance Statement: Poor sleep is known to be related to kidney function impairment. Using the UK Biobank cohort, including individuals self-reporting regular sleep patterns of short, intermediate, or long duration, the authors found that short or long sleep duration was associated with higher prevalence of CKD. In the genetic analysis, the genetic risk score for short but not long sleep duration was significantly related to a higher risk of CKD stages 3–5, suggesting causal effects of short sleep duration on CKD. Two-sample Mendelian randomization analysis, using the independent meta-analysis results of kidney function from the CKDGen Consortium genome-wide association study, also showed significant causal estimates of short sleep duration on CKD. Clinicians may thus consider encouraging patients to avoid short-duration sleeping behavior to reduce the risk of CKD. Background: Studies have found sleeping behaviors, such as sleep duration, to be associated with kidney function and cardiovascular disease risk. However, whether short or long sleep duration is a causative factor for kidney function impairment has been rarely studied. Methods: We studied data from participants aged 40–69 years in the UK Biobank prospective cohort, including 25,605 self-reporting short-duration sleep (<6 hours per 24 hours), 404,550 reporting intermediate-duration sleep (6–8 hours), and 35,659 reporting long-duration sleep (≥9 hours) in the clinical analysis. Using logistic regression analysis, we investigated the observational association between the sleep duration group and prevalent CKD stages 3–5, analyzed by logistic regression analysis. We performed Mendelian randomization (MR) analysis involving 321,260 White British individuals using genetic instruments (genetic variants linked with short- or long-duration sleep behavior as instrumental variables). We performed genetic risk score analysis as a one-sample MR and extended the finding with a two-sample MR analysis with CKD outcome information from the independent CKDGen Consortium genome-wide association study meta-analysis. Results: Short or long sleep duration clinically associated with higher prevalence of CKD compared with intermediate duration. The genetic risk score for short (but not long) sleep was significantly related to CKD (per unit reflecting a two-fold increase in the odds of the phenotype; adjusted odds ratio, 1.80; 95% confidence interval, 1.25 to 2.60). Two-sample MR analysis demonstrated causal effects of short sleep duration on CKD by the inverse variance weighted method, supported by causal estimates from MR-Egger regression. Conclusions: These findings support an adverse effect of a short sleep duration on kidney function. Clinicians may encourage patients to avoid short-duration sleeping behavior to reduce CKD risk.

23 May 2021 in European Heart Journal
Verified
Journal Article
Open access
PDF file
SPSehoon Park
Sehoon Park
SLSoojin Lee
Soojin Lee
YKYaerim Kim
Yaerim Kim
YLYeonhee Lee
Yeonhee Lee
MKMin Woo Kang
Min Woo Kang
DKDong Ki Kim
Dong Ki Kim
The aim of this study was to investigate the causal effects between atrial fibrillation (AF) and kidney function. We performed a bidirectional summary-level Mendelian randomization (MR) analysis implementing the results from a large-scale genome-wide association study for estimated glomerular filtration rate (eGFR) by the CKDGen (N = 765 348) and AF (N = 588 190) to identify genetic instruments. The inverse variance weighted method was the main MR method used. For replication, an allele score-based MR was performed by individual-level data within a UK Biobank cohort of white British ancestry individuals (N = 337 138). A genetic predisposition to AF was significantly associated with decreased eGFR [for log-eGFR, beta −0.003 (standard error, 0.0005), P < 0.001] and increased risk of chronic kidney disease [beta 0.059 (0.0126), P < 0.001]. The significance remained in MR sensitivity analyses and the causal estimates were consistent when we limited the analysis to individuals of European ancestry. Genetically predicted eGFR did not show a significant association with the risk of AF [beta −0.366 (0.275), P = 0.183]. The results were similar in allele score-based MR, as allele score for AF was significantly associated with reduced eGFR [for continuous eGFR, beta −0.079 (0.021), P < 0.001], but allele score for eGFR did not show a significant association with risk of AF [beta −0.005 (0.008), P = 0.530]. Our study supports that AF is a causal risk factor for kidney function impairment. However, an effect of kidney function on AF was not identified in this study. This study supports that atrial fibrillation is a causal factor for kidney function impairment, although causal effects from kidney function on the risk of atrial fibrillation was inapparent.

30 June 2020 in Kidney Research and Clinical Practice
Verified
Journal Article
Open access
PDF file
SPSehoon Park
Sehoon Park
SLSoojin Lee
Soojin Lee
YKYaerim Kim
Yaerim Kim
YLYeonhee Lee
Yeonhee Lee
MKMin Woo Kang
Min Woo Kang
DKDong Ki Kim
Dong Ki Kim
Sehoon Park , Soojin Lee , Yaerim Kim , Yeonhee Lee , Min Woo Kang , Kyungdo Han , Hajeong Lee , Jung Pyo Lee , Kwon Wook Joo , Chun Soo Lim , Yon Su Kim , Dong Ki Kim. Kidney Res Clin Pract 2020;39:180-91. https://doi.org/10.23876/j.krcp.20.016

20 January 2019 in Nephrology
Verified
Journal Article
Open access
PDF file
YCYeoungjee Cho
Yeoungjee Cho
BSBenedicte Sautenet
Benedicte Sautenet
TGTalia Gutman
Talia Gutman
GRGopi Rangan
Gopi Rangan
JCJonathan C Craig
Jonathan C Craig
ATAllison Tong
Allison Tong
Aim: Patients with autosomal dominant polycystic kidney disease (ADPKD) are at increased risk of premature mortality, morbidities and complications, which severely impair quality of life. However, patient‐centered outcomes are not consistently reported in trials in ADPKD, which can limit shared decision‐making. We aimed to identify outcomes important to patients and caregivers and the reasons for their priorities.Methods: Nominal group technique was adopted involving patients with ADPKD and caregivers who were purposively selected from eight centres across Australia, France and the Republic of Korea. Participants identified, ranked and discussed outcomes for trials in ADPKD. We calculated an importance score (0–1) for each outcome and conducted thematic analyses.Results: Across 17 groups, 154 participants (121 patients, 33 caregivers) aged 19 to 78 (mean 54.5 years) identified 55 outcomes. The 10 highest ranked outcomes were: kidney function (importance score 0.36), end‐stage kidney disease (0.32), survival (0.21), cyst size/growth (0.20), cyst pain/bleeding (0.18), blood pressure (0.17), ability to work (0.16), cerebral aneurysm/stroke (0.14), mobility/physical function (0.12), and fatigue (0.12). Three themes were identified: threatening semblance of normality, inability to control and making sense of diverse risks.Conclusion: For patients with ADPKD and their caregivers, kidney function, delayed progression to end‐stage kidney disease and survival were the highest priorities, and were focused on achieving normality, and maintaining control over health and lifestyle. Implementing these patient‐important outcomes may improve the meaning and relevance of trials to inform clinical care in ADPKD.

1 June 2021 in Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
PDF file
SPSehoon Park
Sehoon Park
SLSoojin Lee
Soojin Lee
YKYaerim Kim
Yaerim Kim
YLYeonhee Lee
Yeonhee Lee
MKMin Woo Kang
Min Woo Kang
DKDong Ki Kim
Dong Ki Kim
Significance Statement: Poor psychologic wellbeing is prevalent in people with kidney function impairment. A Mendelian randomization investigation identified “causal” effects from psychologic wellbeing on kidney function. The analysis demonstrated that genetic predisposition for certain positive wellbeing senses causally decreases the risk of kidney function impairment. In contrast, genetically predicted negative wellbeing senses were causally linked to a higher risk of CKD, or a lower eGFR. Therefore, this study suggests health care providers in the nephrology field should be aware of the causal linkage between psychologic wellbeing and kidney function. Background: Further investigation of the causal effects of psychologic wellbeing on kidney function is warranted. Methods: In this Mendelian randomization (MR) study, genetic instruments for positive affect, life satisfaction, depressive symptoms, and neuroticism were introduced from a previous genome-wide association study meta-analysis of European individuals. Summary-level MR was performed using the CKDGen data of European ancestry (n=567,460), and additional allele score–based MR was performed in the individual-level data of White British UK Biobank participants (n=321,024). Results: In summary-level MR with the CKDGen data, depressive symptoms were a significant causative factor for kidney function impairment (CKD OR, 1.45; 95% confidence interval, 1.07 to 1.96; eGFR change [%] beta −2.18; 95% confidence interval, −3.61 to −0.72) and pleiotropy-robust sensitivity analysis results supported the causal estimates. A genetic predisposition for positive affect was significantly associated with better kidney function (CKD OR, 0.69; 95% confidence interval, 0.52 to 0.91), eGFR change [%] beta 1.50; 95% confidence interval, 0.09 to 2.93) and sensitivity MR analysis results supported the finding for CKD outcome, but was nonsignificant for eGFR. Life satisfaction and neuroticism exposures showed nonsignificant causal estimates. In the UK Biobank with covariate-adjusted allele score MR analysis, allele scores for positive affect and life satisfaction were causally associated with reduced risk of CKD and higher eGFR. In contrast, neuroticism allele score was associated with increased risk of CKD and lower eGFR, and depressive symptoms allele score was associated with lower eGFR, but showed nonsignificant association with CKD. Conclusions: Health care providers in the nephrology field should be aware of the causal linkage between psychologic wellbeing and kidney function.

16 May 2020 in American Journal of Transplantation
Verified
Journal Article
Open access
YKYaerim Kim
Yaerim Kim
OKOhyun Kwon
Ohyun Kwon
JPJin H. Paek
Jin H. Paek
WPWoo Y. Park
Woo Y. Park
KJKyubok Jin
Kyubok Jin
SHSeungyeup Han
Seungyeup Han
The fatality of novel coronavirus disease 2019 (COVID-19) is precipitously increased in patients with underlying comorbidities or elderly people. Kidney transplant (KT) recipients are one of the vulnerable populations for infection. COVID-19 infection in KT recipients might be a complicated and awkward situation, but there has been a lack of reports concerning this group. Herein, we demonstrated two distinct cases with different clinical progress. The first case was a 36-year-old man who underwent KT 3 years ago. He was diagnosed with COVID-19 expressing relevant symptoms. Following administration of lopinavir/ritonavir and hydroxychloroquine with reduced immunosuppressant, he recovered from COVID-19. However, the unexpected fluctuations in tacrolimus trough levels needed to be managed because of drug-to-drug interaction. The second case was developed in a 56-year-old man without any symptoms. He received a second KT from an ABO-incompatible donor 8 years ago. He was diagnosed with COVID-19 by screening due to exposure history. During the hospitalization period, the chest infiltrative lesion showed a wax and wane, but he successfully recovered by administration of hydroxychloroquine with azithromycin. These apparently different cases suggest that assertive screening and management could improve the clinical course. In addition, antiviral agents should be used cautiously, especially in patients on calcineurin inhibitors.